Adverum Biotechnologies, Inc. (ADVM)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 11.73 |
| Open | 11.72 |
| Bid | 11.52 x 100 |
| Ask | 11.62 x 100 |
| Day's range | 11.37 - 11.98 |
| 52-week range | 7.10 - 29.70 |
| Volume | |
| Avg. volume | 279,990 |
| Market cap | 239.304M |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Are Medical Stocks Lagging Adverum Biotechnologies (ADVM) This Year?
Here is how Adverum Biotechnologies (ADVM) and Cigna (CI) have performed compared to their sector so far this year.
- Zacks
How Adverum (ADVM) Stock Stands Out in a Strong Industry
Adverum (ADVM) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- Zacks
Down -28.72% in 4 Weeks, Here's Why Adverum Biotechnologies (ADVM) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Adverum Biotechnologies (ADVM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
© 2024 Yahoo. All rights reserved.